Loading…
Laboratorio Chile | Teva plans to increase production at its Maipú plant in Chile from 2.3 billion to 3 billion doses annually by 2026, a 30% increase, and further to 3.6 billion doses by 2028, requiring capacity and technology expansion.
| Site | Largest | Latest |
|---|---|---|
| Maipú, Chile | 2023-03-24 |